MEPOLIZUMAB

mepolizumab 100 mg/mL injection, 1 mL pen device
Manner of administration:Injection
Public
S100 HSD Public
Authority Required

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $1,556.10 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Nucala